in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—24 December 2013
2:20 AM MST | December 24, 2013 | Deepti Ramesh
Perrigo completes acquisition of Elan for $8.6 billion Health-care products firm Perrigo (Allegan, MI) says that it has completed the previously announced acquisition of biotechnology company Elan (Dublin), for about $8.6 billion. Perrigo and Elan have been combined under a new company incorporated in Ireland and have adopted the global name Perrigo Co. plc. Shares of Perrigo will trade on the New York Stock Exchange and the Tel Aviv Stock Exchange. Perrigo develops, manufactures, and distributes OTC and generic prescription pharmaceuticals, nutritional products...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee